Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Imac Holdings Inc (BACK)
Imac Holdings Inc (BACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,662
  • Shares Outstanding, K 1,138
  • Annual Sales, $ 16,190 K
  • Annual Income, $ -18,310 K
  • 60-Month Beta 0.18
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BACK with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +1,427,242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +8.15%
on 02/23/24
2.3600 -38.14%
on 02/02/24
-0.6300 (-30.14%)
since 01/23/24
3-Month
1.3100 +11.45%
on 12/13/23
5.3999 -72.96%
on 12/26/23
-0.1900 (-11.52%)
since 11/22/23
52-Week
1.2201 +19.66%
on 11/09/23
10.6200 -86.25%
on 04/11/23
-4.9900 (-77.36%)
since 02/23/23

Most Recent Stories

More News
Moore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

VECT : 16.85 (unch)
EMBK : 2.88 (+0.35%)
BACK : 1.4600 (-0.36%)
RADI : 15.00 (+0.20%)
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

/PRNewswire/ -- Theralink Technologies, Inc. (OTC: THER) ("Theralink") and IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC"), today announced that they have entered...

BACK : 1.4600 (-0.36%)
Biote Announces Strategic Partnership with IMAC Holdings, Inc.

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that it has entered...

BTMD : 6.05 (+10.20%)
BACK : 1.4600 (-0.36%)
Option Volatility And Earnings Report For Dec 20 - 23

Even though the bulk of earnings season has passed, we still have a few big names reporting earnings this week including Nike, Micron Technology and General Mills. Let's see what the option market is telling...

NKE : 105.63 (+0.52%)
MU : 86.00 (+0.10%)
BHP : 58.31 (-0.09%)
CTAS : 633.10 (+0.96%)
PAYX : 124.64 (-0.06%)
GIS : 65.32 (+0.38%)
NVDA : 788.17 (+0.36%)
PFE : 27.76 (+0.76%)
BABA : 75.96 (-0.21%)
ATVI : 94.42 (-0.05%)
COIN : 165.98 (-2.88%)
ADBE : 553.44 (+2.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

IMAC Holdings Inc. is a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids. It owns or manages outpatient clinics which provide regenerative, orthopedic and minimally invasive procedures and therapies. The company's outpatient medical clinics emphasize...

See More

Key Turning Points

3rd Resistance Point 1.9563
2nd Resistance Point 1.8131
1st Resistance Point 1.6365
Last Price 1.4600
1st Support Level 1.3167
2nd Support Level 1.1735
3rd Support Level 0.9969

See More

52-Week High 10.6200
Fibonacci 61.8% 7.0292
Fibonacci 50% 5.9201
Fibonacci 38.2% 4.8109
Last Price 1.4600
52-Week Low 1.2201

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar